Peripheral Vascular Devices | Market Insights | Japan | 2024
The Japanese PV device market will continue to experience modest growth through 2032 primarily due to growth in the endovascular procedure volumes along with the rising adoption of premium-priced devices such as DCBs and DES. However, revenue growth will be limited to some extent due to ASP declines caused by MHLW biennial reimbursement cuts over the forecast period.
This Medtech 360 Report provides comprehensive data and analysis on the state of the market for PV devices in Japan from 2019 through 2032.